This study demonstrated that patients with more complex forms of AF (3D-PAF or 3B/3C/3D-persistent/LSPAF) could be well managed with a convergent approach. In a real-world evaluation, outcomes match safety and efficacy thresholds achieved for patients with earlier, less complex AF etiologies treated by CB PVI alone.
Raquel SeguraNatalia Abuín VencesAlberto García García
Giselle Aurelia Rodríguez CaballeroAna CaballeroMaría FustéLeidy Virginia Realpe CancioCynthia MartínezVanessa MiderosAlexander Gorina SánchezMaría MartínNelvis GorinaIrina LozadaE. RomeroAlexis Céspedes QuialaNadia BarrabíMaría NúñezJ. Jiménez LópezYumilka GalbánR. CastañedaJ González HernándezGisela ValónRosa María Romero GonzálezM Dore ReyesL. SuárezMayenin Fuentes TurRamiro GrossMariela SaméD. Catalán MatamorosMaría DíazVeronica Cadena
Yessenia Isabel Fallas Jiménez
Erika Fernández-GómezBeatriz Feijóo
Sonia Agley Bustinza ChoquehuancaLilia Maribel Angulo MamaniKatty Maribel Calderón QuinoDamiana Flores Mamani